News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|July 26, 2022

Fezolinetant making waves for VMS

Author(s)Morgan Ebert, Managing Editor

Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

FDA approves Aptima HPV assay for clinician-collected primary cervical cancer screening

FDA approves Aptima HPV assay for clinician-collected primary cervical cancer screening

ByBenjamin P. Saylor

February 4th 2026

Recapping January's top Contemporary OB/GYN headlines | Image Credit: © sebra- stock.adobe.com.

Recapping January's top Contemporary OB/GYN headlines

ByJoshua Fitch, Senior Editor

February 3rd 2026

Rheumatoid arthritis deaths among postmenopausal women decline from 1999 to 2023 | Image Credit: © Valentina - © Valentina - stock.adobe.com.

Rheumatoid arthritis deaths among postmenopausal women decline from 1999 to 2023

ByJoshua Fitch, Senior Editor

January 27th 2026

Menopause associated with adverse mental health, reduced grey matter volume | Image Credit: © Olivier Le Moal - © Olivier Le Moal - stock.adobe.com.

Menopause associated with adverse mental health, reduced grey matter volume

ByJoshua Fitch, Senior Editor

January 27th 2026

Aviva to advance, announce new data for AVA-291 women's testosterone therapy | Image credit: Contemporary OB/GYN

Aviva to advance, announce new data for AVA-291 women's testosterone therapy

ByJoshua Fitch, Senior Editor

January 26th 2026

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

FDA approves Aptima HPV assay for clinician-collected primary cervical cancer screening

Fionnuala McAuliffe, MD, highlights importance of timely breastfeeding discussions with patients

Kevin Ault, MD, on maternal immunization, following the correct recommendations

ACOG calls for safe, equitable ob-gyn care for immigrants

Pregnancy vaccination FAQs: ACOG guidance on COVID-19, flu, and RSV